Tuesday · October 6, 2026
Emerging

Low-FODMAP Diet Cuts Abdominal Pain in Kids With IBS, Meta-Analysis Finds

A new systematic review and meta-analysis of 10 studies in 612 children finds a low-FODMAP diet meaningfully eases abdominal pain in pediatric irritable bowel syndrome, but the benefit largely disappears in functional abdominal pain without a clear IBS diagnosis.

Low-FODMAP Diet Cuts Abdominal Pain in Kids With IBS, Not Functional Pain

If your child's stomach pain has sent you down a research rabbit hole about gut bacteria and food triggers, a new meta-analysis gives the first clear look at whether a low-FODMAP diet (a temporary elimination diet that restricts fermentable carbohydrates the gut ferments into gas) actually helps kids, and where it falls short.

Researchers pooled data from 10 studies covering 612 children and teenagers with chronic, unexplained abdominal pain and found the diet significantly eased pain overall, but the benefit was concentrated almost entirely in children diagnosed with irritable bowel syndrome (IBS), not in those with the vaguer diagnosis of functional abdominal pain (FAP). The effect sizes are large on paper, but the underlying evidence is thin: most studies lacked control groups, and the researchers themselves rate confidence in the findings as very low.

Key takeaways

  • A low-FODMAP diet significantly reduced abdominal pain intensity across 612 pediatric patients in a pooled analysis of 10 studies (SMD -1.37).
  • The benefit was driven almost entirely by children with irritable bowel syndrome (SMD -2.17); kids with functional abdominal pain saw a much smaller effect (SMD -0.36).
  • Most of the underlying studies had no control group and a high risk of bias, so the reviewers rate the certainty of this evidence as very low.
  • The diet did not change how often kids went to the bathroom, and researchers say larger, controlled trials are still needed before it can be broadly recommended.

Low-FODMAP Diet Significantly Eased Pediatric Abdominal Pain

A systematic review and meta-analysis published in the Journal of Parenteral and Enteral Nutrition found that a low-FODMAP diet produced a large, statistically significant reduction in abdominal pain intensity among children and adolescents with disorders of gut-brain interaction (DGBIs, a category of chronic digestive conditions with no visible structural cause), with a standardized mean difference (SMD, a way of comparing effect sizes across studies that use different pain scales) of -1.37. FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols, a group of short-chain carbohydrates found in foods like wheat, onions, garlic, beans, and some fruits that resist digestion and get fermented by gut bacteria, producing gas and drawing water into the intestine. Nine of the 10 included studies contributed data on this outcome, and the researchers, led by a team from Federal University of Sergipe in Brazil, pooled results from a total of 612 pediatric patients treated with the diet.

Kids With IBS Benefited Far More Than Those With Functional Pain

The finding matters most for the roughly 1 in 5 children worldwide affected by DGBIs, chronic conditions marked by recurring abdominal pain that can derail school attendance and quality of life. But the study drew a sharp line between two related diagnoses. Children with irritable bowel syndrome, defined by recurring pain tied to changes in bowel habits, saw the largest improvement (SMD -2.17), and their pain frequency and overall treatment satisfaction (83%) improved too. Children with functional abdominal pain, a diagnosis for recurring pain without the bowel-habit changes that define IBS, saw a much smaller and less consistent benefit (SMD -0.36 for pain intensity, and no significant change in pain frequency), with lower satisfaction (43%). The difference between the two groups was statistically significant, meaning this was not random noise. For a parent, the takeaway is that a specific IBS diagnosis, not just "stomach pain," appears to be what predicts whether this diet is worth discussing.

Ten Studies, 612 Children, but Almost No Control Groups

The researchers followed PRISMA guidelines and pre-registered their protocol with PROSPERO before searching four databases (PubMed, Embase, CENTRAL, and Web of Science) through May 2025. Of 371 initial records, 10 studies met their criteria: eight evaluated outcomes in children with IBS and six in children with FAP, with total follow-up periods ranging from just 2 days in one study to 8 weeks in another. Crucially, this was what the authors call a "single-arm" meta-analysis: most of the included studies did not compare the diet against a placebo or a normal diet, but instead measured how each child's own symptoms changed before and after starting the diet. The authors are explicit that this design choice inherently risks overestimating how well the diet actually works, since it can't rule out that symptoms simply improved over time on their own.

What This Means If You're Considering the Diet for Your Child

Nothing here supports simply cutting FODMAPs from a child's diet on your own. The low-FODMAP diet is a structured elimination-and-reintroduction protocol, not a permanent restriction, and it works best (and is generally considered safest) when supervised by a pediatric dietitian, since restrictive diets in children carry a real risk of inadequate nutrition. If your child has been diagnosed with IBS specifically, and pain relief and satisfaction data here were meaningfully stronger for that group, this study adds weight to a conversation with a gastroenterologist or dietitian about a trial run. If the diagnosis is functional abdominal pain without a clear IBS component, this data does not make a strong case for the diet, and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) has previously stated there is only scarce evidence to support the low-FODMAP diet in pediatric IBS and no evidence to recommend it for other functional gastrointestinal complaints in children.

Why the Evidence Is Weaker Than the Numbers Suggest

Two things temper how much weight these numbers should carry. First, heterogeneity, meaning how much the results varied from study to study, was substantial (as high as 93% for pain intensity), which reflects real differences in study design, follow-up length, and patient populations rather than one consistent effect. Second, the researchers formally graded the certainty of evidence using the GRADE framework and rated most outcomes, including pain intensity, pain frequency, and stool frequency, as very low certainty. That downgrade came from a combination of the missing control groups, inconsistent results between studies, and small sample sizes for some outcomes; notably, the reported 43% satisfaction figure for the FAP group came from a single small study. The diet also showed no significant effect on stool frequency, so it does not appear to change bowel habits even where it eases pain.

Larger, Controlled Trials Are the Clear Next Step

The study authors are blunt that their own findings call for confirmation, not adoption: they state that larger, well-controlled pediatric trials are needed to confirm efficacy, evaluate long-term nutritional safety, and define how the diet should factor into long-term management of these conditions. No funding source or conflict of interest was declared for this review, and there is no stated timeline for when such trials might report results.

Common Questions

Is the low-FODMAP diet safe for children to try on their own? This study did not evaluate long-term safety, and restrictive diets in children carry a risk of inadequate nutrition if not properly managed, so the diet is generally recommended only under the guidance of a pediatric dietitian.

Does this study prove the low-FODMAP diet works for kids with stomach pain? No. It found a significant benefit specifically in children diagnosed with IBS, but the authors rate the overall certainty of evidence as very low because most studies lacked control groups and had a high risk of bias.

What's the difference between IBS and functional abdominal pain in this study? IBS is defined by recurring abdominal pain combined with changes in bowel habits, while functional abdominal pain describes recurring pain without those bowel-habit changes; the diet's benefit was much larger and more consistent in the IBS group.

Did the diet change how often children with these conditions used the bathroom? No, the pooled analysis found no significant effect on stool frequency, even in outcomes where pain improved.

Evidence Rating

EMERGING — 80/100

Caveats

  • High between-study heterogeneity (I2 up to 93%)
  • Most included studies were single-arm or observational with a high risk of bias per ROBINS-I; only one included RCT was rated high risk for missing outcome data
  • Single-arm meta-analysis without control groups inherently risks overestimating the diet’s true effect
  • GRADE-rated certainty of evidence was mostly very low across outcomes
  • Some subgroup estimates (e.g., FAP satisfaction) rest on a single small study
  • Larger, controlled pediatric trials are needed to confirm efficacy and long-term nutritional safety
  • No funding source or conflict of interest declared

Systematic review and meta-analysis (PRISMA, PROSPERO-registered) pooling 10 studies (N=612 pediatric patients) on low-FODMAP diet for IBS and functional abdominal pain in children. Found a significant reduction in abdominal pain intensity overall (SMD -1.37), with the effect much larger and more consistent in IBS (SMD -2.17) than functional abdominal pain (SMD -0.36). Pain frequency and satisfaction also improved in IBS but not FAP; stool frequency was unchanged. Most included studies were single-arm/observational with no control group, heterogeneity was substantial (I2 up to 93%), and GRADE-rated certainty of evidence was mostly very low.

References

  1. Pedro Henrique Silva de Oliveira Souza, João Ricardo Coutinho Coêlho, Alexandre Machado de Andrade, et al. (2026). Low‐FODMAP diet for pediatric patients with disorders of gut‐brain interaction: A systematic review and meta‐analysis. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1002/jpen.70135
  2. R.A. Thomassen, V. Luque, A. Assa, et al. (2022). An ESPGHAN Position Paper on the Use of Low‐FODMAP Diet in Pediatric Gastroenterology. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/mpg.0000000000003526